Dr Christine Challen Dr John Anderson Professor Zofia Chrzanowska-Lightowlers Professor Robert Lightowlers Professor John Lunec et al. | Recombinant human MDM2 oncoprotein shows sequence composition selectivity for binding to both RNA and DNA | 2012 |
|
Dr Christine Challen Professor Philip Sloan Professor Mark Birch-Machin Dr Max Robinson
| Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility | 2011 |
|
Seamus Kelly Dr John Anderson Dr Brian Angus Dr Christine Challen Professor John Lunec et al. | The predictive value of p53 and p33ING1b in patients with Dukes'C colorectal cancer | 2008 |
|
Dr Rachel Crossland Dr Christine Challen Dr Bridget Wilkins Dr Stephen Crosier Dr John Anderson et al. | Definitive identification of the Val617Phe mutation in myeloproliferative disorders using Real Time PCR utilising Roche Lightcycler/hybriprobe technology | 2007 |
|
Dr John Anderson Dr Christine Challen Dr Stephen Crosier Professor John Lunec
| MDM2 RNA binding is blocked by novel monoclonal antibody h-MDM2-F4-14 | 2007 |
|
Dr Christine Challen Thomas Griffiths Dr Mary Robinson Professor David Neal Professor John Lunec et al. | Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: High frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosis | 1998 |
|
Dr Christine Challen Professor John Lunec Professor Margaret Bassendine
| Analysis of the p53 tumour suppressor gene in HCCs from Britain. | 1992 |
|
Professor John Lunec Dr Christine Challen Dr Christopher Wright Professor David Neal
| c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder | 1992 |
|
Dr Christine Challen Professor Margaret Bassendine
| Infrequent point mutations in codons 12 and 61 of Ras oncogenes in HCC. | 1992 |
|